IEQ Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.49M Buy
44,777
+4,373
+11% +$153K 0.01% 924
2026
Q2
$1.5M Buy
+40,404
New +$1.23M 0.01% 935
2025
Q3
– Sell
-8,086
Closed -$269K – 1835
2025
Q2
$269K Buy
+8,086
New +$245K ﹤0.01% 1456

Other funds holding AGIO

IEQ Capital's AGIO Position: Q3 2026 in Review

IEQ Capital increased its Agios Pharmaceuticals (AGIO) stake by 11% in Q3 2026, buying an estimated $153K and bringing the position to 44,777 shares worth $1.49M. The position accounts for 0.01% of the portfolio, ranked #924.

IEQ Capital first reported a position in AGIO in Q2 2025 and has held it in 3 quarters since. The position peaked at $1.5M in Q2 2026. 243 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • IEQ Capital held 44,777 shares of Agios Pharmaceuticals worth $1.49M as of Q3 2026.
  • IEQ Capital bought 4,373 Agios Pharmaceuticals shares in Q3 2026, an estimated $153K.
  • Agios Pharmaceuticals made up 0.01% of IEQ Capital's portfolio in Q3 2026, its #924 holding.
  • IEQ Capital first reported a position in Agios Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • IEQ Capital's Agios Pharmaceuticals position peaked at $1.5M in Q2 2026.
  • 243 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.